Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma
| Autor: | Paulina Kozakiewicz, Ludmiła Grzybowska‑Szatkowska |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Cancer Research biology business.industry Afatinib Review Vandetanib medicine.disease Head and neck squamous-cell carcinoma Zalutumumab 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Gefitinib Oncology 030220 oncology & carcinogenesis Cancer research biology.protein Medicine Nimotuzumab Epidermal growth factor receptor Erlotinib business neoplasms medicine.drug |
| Zdroj: | Oncology letters. 15(5) |
| ISSN: | 1792-1074 |
| Popis: | Despite the development of standard therapies, including surgery, radiotherapy and chemotherapy, survival rates for head and neck squamous cell carcinoma (HNSCC) have not changed significantly over the past three decades. Complete recovery is achieved in |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|